Arteris Q3 2025 Earnings Report

Arteris EPS Results

• Actual EPS: -$0.09
• Consensus EPS: -$0.11
• Beat/Miss: Beat by +$0.02
• One Year Ago EPS: N/A

Arteris Revenue Results

• Actual Revenue: $17.41 million
• Expected Revenue: $17.00 million
• Beat/Miss: Beat by +$408.00 thousand
• YoY Revenue Growth: N/A

Arteris Announcement Details

• Quarter: Q3 2025
• Date: 11/4/2025
• Time: After Market Closes
• Conference Call Date: Tuesday, November 4, 2025
• Conference Call Time: 4:30PM ET

Arteris (NASDAQ:AIP) is a semiconductor intellectual property company that provides network-on-chip (NoC) interconnect and system IP for the design of complex systems-on-chip (SoCs). Its technologies help semiconductor and electronics companies connect processor cores, memory, peripherals and other functional blocks within a chip while supporting data movement, system integration and design reuse.

The company’s product portfolio includes FlexNoC interconnect IP, Ncore cache-coherent interconnect IP and CodaCache system IP. Arteris also provides tools and related technologies intended to simplify SoC architecture, integration, verification and configuration. Its solutions are used in applications such as automotive electronics, artificial intelligence and high-performance computing, consumer devices, communications equipment and industrial systems.

Arteris was founded in 2003 and is headquartered in Campbell, California. The company serves semiconductor developers and systems companies internationally and became a publicly traded company on the Nasdaq under the symbol AIP in 2021. Arteris has been led by K. Charles Janac, who serves as president and chief executive officer.

Arteris Q3 2025 Earnings Call Transcript

Key Takeaways

• Positive Sentiment: Company reported a record ACV plus royalties of $74.9M (up 24% YoY) and a new high in Remaining Performance Obligations of $104.7M (up 34% YoY), improving near‑term revenue visibility.
• Positive Sentiment: Q3 revenue of $17.4M beat guidance (up 18% YoY), trailing 12‑month variable royalties grew 36% YoY, and the company delivered positive free cash flow of $2.5M with $56.2M cash and no debt.
• Positive Sentiment: Product and customer momentum accelerated—notable wins and expansions include Altera, incremental licensing from AMD, four new FlexGen customers (including a top EV OEM and NanoExplore), and membership in the UALink Consortium, supporting chiplet/data‑center opportunities.
• Negative Sentiment: The company remains unprofitable on a GAAP basis (Q3 GAAP net loss $9.0M) and expects a full‑year non‑GAAP operating loss of $12.5M–$13.5M as it continues to reinvest in R&D and go‑to‑market.
• Neutral Sentiment: Management expects a multi‑year royalty inflection (3–6+ year lag from design start to high‑volume royalties) with growing diversification of royalty sources and an eventual secular shift toward data‑center exposure (~25–35% long‑term), making near‑term upside contingent on long lead times.

Presentation

[Operator]

Good afternoon, everyone, and welcome to the Arteris third quarter 2025 earnings call. Please note, this call is being recorded and simultaneously broadcast. All materials contained in the webcast are sole property and copyright of Arteris, Inc., with all rights reserved. For opening remarks and introductions, I will now turn the call over to Erica Mannion of Sapphire Investor Relations. Please go ahead.

[Erica Mannion, Partner and Founder at Sapphire Investor Relations]

Thank you, and good afternoon. With me today from Arteris are Charlie Janac, Chief Executive Officer, and Nick Hawkins, Chief Financial Officer. Charlie will begin with a brief review of the business results for the third quarter ended September 30, 2025. Nick will review the financial results for the third quarter, followed by the company's outlook for the fourth quarter and the full year of 2025. We will then open the call for questions. Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities laws. These statements are based on management's current expectations and assumptions and involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated, and you should not place undue reliance on forward-looking statements.

[Erica Mannion, Partner and Founder at Sapphire Investor Relations]

Additional information regarding these risks, uncertainties, and factors that could cause results to differ appears in the press release Arteris issued today and in the documents and reports filed by Arteris from time to time with the Securities and Exchange Commission. Please note, during this call, we will cite certain non-GAAP measures, including, among others, non-GAAP net loss, non-GAAP net loss per share, and free cash flow, which are not measures prepared in accordance with US GAAP. The non-GAAP measures are presented as we believe they provide investors with a means of evaluating and understanding how the company's management evaluates the company's operating performance. These non-GAAP measures should not be considered in isolation from, as substitutes for, or superior to financial measures prepared in accordance with US GAAP.

[Erica Mannion, Partner and Founder at Sapphire Investor Relations]

A reconciliation of these non-GAAP measures to the nearest GAAP measure can be found in the press release for the quarter ended September 30, 2025. In addition, for a definition of the key performance indicators used in this presentation, such as annual contract value, confirmed design starts, and remaining performance obligations, please see the press release for the quarter ended September 30, 2025. These key performance indicators are presented for supplemental informational purposes only, should not be considered a substitute for financial information presented in accordance with GAAP, and may differ from similarly titled metrics or measures used by other companies, securities analysts, or investors. Listeners who do not have a copy of the press release for the quarter ended September 30, 2025, may obtain one by visiting the investor relations section of the company's website at ir.arteris.com.

[Erica Mannion, Partner and Founder at Sapphire Investor Relations]

In addition, management will be referring to the third quarter 2025 earnings presentation, which can be found in the investor relations section of the company's website under the events and presentations tab. Now, I will turn the call over to CEO Charlie Janac.

[Charlie Janac, CEO at Arteris]

Thank you, Erica, and thanks to everyone for joining us on our call today. In the third quarter of 2025, we achieved yet another record annual contract value plus royalties of $74.9 million, resulting in 24% year-over-year growth. We saw increased product adoption in chiplets and SoCs across multiple vertical markets. AI applications accounted for over half of our licensing dollars in the third quarter, reflecting the growing adoption of Arteris System IP technology from data centers to the smart edge. We continue to see growing adoption of our product portfolio by top technology companies. An example of this is Altera, which selected Arteris technology portfolio to streamline design workflows, optimize data movement, and enable intelligent computing across data center, communications, vision, industrial applications, robotics, aerospace, and defense applications.

[Charlie Janac, CEO at Arteris]

This includes our network-on-chip IP products, including Encore and FlexGen, and the Magillem platform for IP block integration and hardware-software integration automation, which Altera plans to use in designing their next generation of FPGA and SoC FPGA solutions. Speaking of FlexGen, last quarter, we announced that AMD licensed the smart NoC IP to provide high-performance data transport in AI chiplets across AMD's broad portfolio from data centers to edge devices. I'm happy to note that in the third quarter, AMD has ordered additional incremental licenses. In addition to the Altera and AMD relationships, we added four other new FlexGen customers in the third quarter. Within the automotive sector. FlexGen was deployed by Dream Chip, a custom SoC design house for high-end automotive semiconductor design. Additionally, a leading automotive OEM adopted FlexGen for next-generation EVs.

[Charlie Janac, CEO at Arteris]

Within the industrial sector, Nanoxplore, a provider of radiation-hardened silicon technology serving the aerospace, defense, avionics, and industrial markets, licensed FlexGen smart NoC IP to address the demanding mission-critical computing requirements in space while supporting their product performance, team productivity, device reliability, and meeting the underlying area and cost targets. This represents another example of our products being used not only for applications on Earth but increasingly in terrestrial orbit, where performance, safety, reliability, and security are essential. These examples illustrate the broad applicability of our new FlexGen smart NoC IP, helping design teams deliver on expanded needs of chiplets and SoCs. Additionally, we expect demand to scale with rising design complexity and the move to advanced boundary nodes, particularly 5 nm, 3 nm, 2 nm, and as we head into the Angstrom era of silicon.

[Charlie Janac, CEO at Arteris]

As the semiconductor industry accelerates efforts to increase performance and efficiency, especially driven by AI workloads at data centers and the edge. We are continuing to see a growing shift from traditional monolithic chips toward chiplets for multi-die SoC architectures, particularly for AI infrastructure and data center applications. One of the key chiplets is the IOHub chiplet, which controls data movement across heterogeneous multi-die SoCs. 2D systems licensed our Encore and FlexNoc Interconnect IPs to develop just such an IOHub chiplet, where Arteris Technology serves to control multi-die data traffic, meeting the high bandwidth, low latency, energy efficiency, and total cost of ownership objectives while meeting the needs of enterprise computing in data centers and cloud infrastructure. In the quarter, we also saw increased adoption of chiplets for high-end automotive applications, including our recently expanded multi-die solution.

[Charlie Janac, CEO at Arteris]

For example, one of our advanced automotive semiconductor customers shifted from a single chip to multi-die SoC architectures for their next-generation ADAS design, leveraging Ncore and FlexNoc IPs for underlying data movement. Aside from various automotive semiconductor companies, we also saw expanded adoption of Arteris technology by automotive OEMs. Two of the top five EV automotive OEM companies expanded their use of silicon-proven Arteris technology with functional safety for their next-generation vehicles, which increasingly include a wider array of advanced electronic functionality. Given the accelerating demand for increasingly advanced chiplets and chips, from the AI surge in the high end to the growing needs of advanced microcontrollers, the needs for more specialized computing are becoming increasingly evident. This trend drives a broad range of specialized processors, or XPUs, for a growing number of applications by providers who increasingly rely on Arteris technology for their underlying connectivity and data movement.

[Charlie Janac, CEO at Arteris]

With our growing ecosystem, we recently announced an expanded collaboration with Alibaba DAMO Academy, enabling better integration and optimized performance between their RISC-V CPU cores and our data movement system IPs. This collaboration is intended to further enable mutual customers to more efficiently design edge AI server communications and automotive chips. Such ecosystem collaborations help enhance support for end customers, enabling them to accelerate their pace of innovation, with a recent example being Axelera AI, a provider of purpose-built hardware acceleration technology for AI inference. They recently expanded the use of Arteris to help accelerate computer vision for edge devices using our technology to help achieve high bandwidth, low latency, and scalability required to optimize their next-generation inference products. The need for ecosystem collaboration is also evident as industry standards continue to evolve.

[Charlie Janac, CEO at Arteris]

In particular, AI data center infrastructure needs are rapidly evolving, driving demand for purpose-built solutions that can better support rapidly expanding AI workloads. To better meet the associated demand from customers, Arteris joined the UALink Consortium, or UALink. The goal of this organization is to establish an optimized scale-up ecosystem across multiple AI accelerators, with Arteris NoC IP serving as data movement transport in chiplets and SoCs. We joined with other companies in the consortium, such as AMD, Astera Labs, AWS, Cisco, Google, HP Enterprise, Intel, Meta, and Microsoft, all of whom deal with high-end computing and some of whom are requesting related support in our products.

[Charlie Janac, CEO at Arteris]

Lastly, I'm proud that Arteris' continuous innovation was recognized with yet another award, this time as the winner of the most innovative technology company of the year by the 22nd Annual International Business Awards, while also being recognized for new FlexGen smart NoC IP and Magillem Registers Integration Automation Software product, both announced earlier this year. We believe the scale and scope of our opportunity remain robust, supported by our current products and strong pipeline of new data movement system IP technologies, as well as growing relationships with the largest and most advanced electronics companies in the world in collaboration with a broader ecosystem. Our customers continue to innovate in exciting high-growth areas across multiple applications, from AI data centers to the edge, autonomous driving, advanced communications, consumer, and industrial use cases. Many of these customers are increasingly turning to our products and solutions to support their innovative designs.

[Charlie Janac, CEO at Arteris]

With that, I'll turn it over to Nick to discuss our financial results in more detail.

[Nick Hawkins, CFO at Arteris]

Thank you, Charlie, and good afternoon, everyone. As I review our third quarter results today, please note that I'll be referring to GAAP as well as non-GAAP metrics. Reconciliation of GAAP to non-GAAP financials is included in today's earnings release, which is available on our website. Also, as a reminder, I will be referring to the 3Q 2025 earnings presentation, which can be found in the investor relations section of the company's website under the events and presentations tab. We had a strong third quarter, meeting or beating our guidance on all financial measures. Turning to slide five of the presentation. Total revenue for the third quarter was $17.4 million. Up 5% sequentially and 18% year-over-year, and above the top end of our guidance range. Notably, trailing 12-month variable royalties was 36% higher year-over-year.

[Nick Hawkins, CFO at Arteris]

At the end of the third quarter, annual contract value plus royalties was $74.9 million, up 24% year-over-year, above the top end of our guidance range and at a new record high. Remaining performance obligations, which is our contracted future revenue, at the end of the third quarter was $104.7 million, representing a 34% year-over-year increase. A new high and exceeding the $100 million milestone for the first time. Non-GAAP gross profit for the quarter was $15.9 million, representing a gross margin of 91%. GAAP gross profit for the quarter was $15.6 million, representing a gross margin of 90%. Now, turning to slide six. Non-GAAP operating expense for the quarter was $19.5 million. We continue to reinvest a portion of our top-line growth into technology innovations, solution support, and our global sales team. Total GAAP operating expense for the third quarter was $24.4 million.

[Nick Hawkins, CFO at Arteris]

We believe that our ongoing investments will help accelerate our top-line growth in the coming years. At the same time, we are delivering operating leverage by controlling G&A spending, which has now remained broadly flat on a non-GAAP basis for over three years. This has resulted in a 15% improvement of non-GAAP operating expense as a percentage of revenue for the year to date compared to the same period in 2023. Non-GAAP operating loss in the quarter was $3.5 million, in line with our guidance. GAAP operating loss for the third quarter was $8.7 million compared to a loss of $7.9 million in the prior year period. Non-GAAP net loss for the quarter was $3.8 million, or diluted net loss per share of $0.09, based on approximately 42.7 million weighted average diluted shares outstanding.

[Nick Hawkins, CFO at Arteris]

GAAP net loss in the quarter was $9 million, or diluted net loss per share of $0.21. Moving to slide seven and turning to the balance sheet and cash flow. We ended the quarter with $56.2 million in cash, cash equivalents, and investments, and we have no financial debt. Free cash flow, which includes capital expenditure, was +$2.5 million for the third quarter, above the midpoint of our guidance range. I would now like to turn to our outlook for the fourth quarter and the full year 2025 and refer now to slide eight. For the fourth quarter 2025, we expect ACV plus royalties of $74 million-$78 million. Revenue of $18.4 million-$18.8 million, with non-GAAP operating loss of $2.3 million-$3.3 million, and non-GAAP free cash flow of $0.2 million-$3.2 million. For the full year 2025, our guidance is as follows.

[Nick Hawkins, CFO at Arteris]

ACV plus royalties to exit 2025 at $74 million-$78 million, an increase of $1 million compared to our prior guidance. Revenue of $68.8 million-$69.2 million, also an increase of $1 million compared to our prior guidance. Non-GAAP operating loss of between $12.5 million-$13.5 million, and non-GAAP free cash flow of $2.5 million-$5.5 million. We remain encouraged by our strong deal execution, witnessed by the 34% year-over-year growth in RPO at the end of the third quarter. We are seeing promising signs of accelerated interest by some major customers to increase their outsourcing of system IP products to Arteris, which we believe will help accelerate growth in our license and royalty revenue, ACV plus royalties, RPO, and positive free cash flow. With that, I will turn the call back to the operator for the Q&A portion of the call. Operator.

[Operator]

Thank you. Ladies and gentlemen, we'll now begin the question-and-answer session. Should you have a question, please press the star followed by the number one on your touch-tone phone. You will hear a prompt that your hand has been raised. Should you wish to decline from the polling process, please press the star followed by the number two. If you are using a speakerphone, please lift the handset before pressing any keys. One moment, please, for your first question. Your first question is from Kevin Garrigan from Jefferies. Please go ahead.

[Kevin Garrigan, Equity Research Analyst at Jefferies]

Yeah, hey, Charlie and Nick. Congrats on the results and the Altera announcement. Can you just talk a little bit more about Altera? Are they fully away from using internal interconnect teams, or is there still more opportunities for you guys to expand there?

[Charlie Janac, CEO at Arteris]

I think there's more opportunities. Basically, the application is for FPGAs and FPGA SoCs. So. Altera is using their own interconnect in the FPGA matrix, and then we are used essentially in the SoC part. But Altera business is going to continue to evolve and grow, and we believe that there's future opportunities. But this is a major milestone because Altera, as they spun out of Intel, chose to go with Arteris for their primary system IP requirements. But yes, there is more potential going down the road.

[Kevin Garrigan, Equity Research Analyst at Jefferies]

Okay. Perfect. And then, since the initial discussions with AMD and the initial order announcement, it seems like it took about one quarter, maybe a little bit longer, for them to expand the use of your product. So what were they kind of most impressed with that led to increasing usage in such a short time frame?

[Charlie Janac, CEO at Arteris]

Yeah. I mean, AMD is a big company. The deal in the second quarter was for basically their central engineering group. And the third quarter deal was basically for another group. And Altera has, I'm sorry, AMD has many groups for us to work with. And so there are also additional opportunities at AMD, and we're very much looking forward to helping them accelerate their chip deliveries.

[Kevin Garrigan, Equity Research Analyst at Jefferies]

Got it. Got it. Okay. And just one more, if I can. Can you just talk a little bit more about the importance of reliability and safety when it comes to interconnects and the importance of it in some end markets like spaces you guys mentioned? And I think you guys have done a very good job on this front, but do you see this focus as really a competitive advantage for you guys?

[Charlie Janac, CEO at Arteris]

Oh, absolutely. I mean, basically, all the important data goes through our network on chips. And basically, if that has problems or doesn't work, the chip doesn't work. So customers are very risk-averse in choosing system IP solutions because any problems there can cause major delays in tape-outs and field problems. So we're being recognized as very much a silicon-proven company. I think now our installed base has shipped something like 3.9 billion SoCs, and they all work. And probably some of the stuff used daily probably has Arteris interconnect in it. So yes, we are very much focused on reliability. We're very much focused on quality because if the system IP doesn't work, the chip doesn't work.

[Kevin Garrigan, Equity Research Analyst at Jefferies]

Yep. Got it. Got it. Okay. Perfect. I appreciate the color. Congrats again.

[Charlie Janac, CEO at Arteris]

Thank you.

[Operator]

The next question is from Kevin Cassidy from Rosenblatt Securities. Please go ahead.

[Kevin Cassidy, Analyst at Rosenblatt Securities]

Yeah. Thanks for taking my question, and congratulations on the great momentum. Just on the UALink Consortium, what kind of timing can we expect for licenses to come out of that consortium and some of the players there?

[Charlie Janac, CEO at Arteris]

Well, some of the players are already customers. But basically, the objective of the UALink Consortium is to essentially scale up data center solutions. And so we're basically developing technology to support that. And we're already involved in some of those designs, but we're basically following that consortium's protocol in order to support the data center scale-up efforts that are pioneered by the companies that we mentioned.

[Kevin Cassidy, Analyst at Rosenblatt Securities]

Okay. Great. And with the penetration you're getting within AMD and combining it with the Altera announcement, is there opportunities for Xilinx, or is that already included in your AMD discussion?

[Charlie Janac, CEO at Arteris]

Xilinx is an important part of AMD. In fact, Xilinx was the first customer that was involved with us prior to the AMD acquisition. Xilinx has been a long-time user of Arteris.

[Kevin Cassidy, Analyst at Rosenblatt Securities]

Okay. Thank you.

[Operator]

Your next question is from Gus Richard from Northland. Please go ahead.

[Gus Richard, Analyst at Northland]

Yes. Thanks for taking the question. Real quick. You've had a number of design wins for a while, and just wondering, the royalty relative to most mature IP companies is relatively low. Just wondering, when do you expect that to start to accelerate?

[Charlie Janac, CEO at Arteris]

Nick, do you want to take that one?

[Nick Hawkins, EVP and CFO at Arteris]

Yep. I will. Yeah, so hi, Gus. Welcome to the call. It's a great question because as you and I have discussed in the past, an increasing rate of customer design starts is a great indicator of future royalty growth because typically, there's somewhere between a three- to six-year lag between the start of a design and mass production and scale. And it can take even another couple of years to get up to full scale after the mass production starts. So it is definitely a heavy link between the two. We're already seeing that, and we're already seeing the beginning of the inflection on royalty. And there's one you'll see in our investor deck, our Q3 investor deck. There's a new additional piece of information on royalties. And what's very interesting is, number one, the growth of variable royalties is quite impressive.

[Nick Hawkins, CFO at Arteris]

And in fact, the growth year over year for the variable royalties in the trailing 12 months to the end of September compared to the prior 12 months ending September 30, 2024, was up 36%, which is in line with what we've been saying in terms of the royalties growing at roughly 2x the rate of licenses. And what's particularly interesting in that chart you'll see in the investor deck is that if you go back to 2020, which is quite an interesting start point because that's when we were dominated in royalties from HiSilicon, which has now, of course, gone to zero. We now have a higher rate of variable royalties. In fact, higher than all years since the days of HiSilicon back in 2020.

[Nick Hawkins, CFO at Arteris]

And now, instead of it being a one-trick pony, where we had one customer making up 90% of our variable royalties, we now have five customers who, between them, have a greater royalty stream than the one HiSilicon. So we've got more diversity. We've got more people who are now the majors. So it's five majors and then another 50 smaller players. And so it's all up and to the right and growing very nicely. So we are starting to see that. I do see there's an increasing inflection point as we go through the next couple of years. By 2028, you'll see an even faster rate of acceleration.

[Gus Richard, Analyst at Northland]

Got it. That was super helpful. And then, Charlie, for you. You guys talk about the top tech companies that you've penetrated. I was wondering if they, just for everybody, define what those companies are and then how many you've, at this point, penetrated. And then specifically in the AI ASIC crowd, are you starting to penetrate those, both U.S. and Taiwan?

[Charlie Janac, CEO at Arteris]

Yeah. I mean, basically, we define the large companies as sort of top 20 semiconductor companies and then basically another 20 of the largest system electronics companies, right? So we're kind of jokingly referring to that as the Arteris index, and we have, I would say, more than 50% of those companies as customers, but not all of them are huge customers, right? So there's still a long way to go in terms of expansion of our business. But obviously, with the AMD and Altera announcement, and there's a couple others who don't let us announce who they are, one of which we also closed in the Q3. We did our best to be able to announce them, but they did not let us. So I think our progress in the top 40 largest technology companies is quite good, but there's a long way to go.

[Charlie Janac, CEO at Arteris]

It's about a $1.2 billion market, and we're about $68 million this year or something like that. So there's a long way to go.

[Gus Richard, Analyst at Northland]

Okay. Got it. And then the floor's open for more questions. When I go through cash flow and balance sheet, blah, blah, and it looks like bookings were in the ZIP code of $32 million in the quarter, book-to-bill about $1.8 million. So. Nick, am I in the right ZIP code?

[Nick Hawkins, CFO at Arteris]

Yeah. I don't want to comment on bookings. Otherwise, we open up a Pandora's box of future disclosure. So bookings is, as you know, fairly lumpy. And so, because we have very large customers these days, and so that can really create a false precedent if we start disclosing that. So, I'll have to allow you to do your own math on bookings, Gus.

[Gus Richard, Analyst at Northland]

Okay. Yeah. I figured. Thanks. I'll pass it on.

[Operator]

Your next question is from Joshua Buchalter from TD Cowen. Please go ahead.

[Joshua Buchalter, Senior Equity Research Analyst at TD Cowen]

Hey, guys. Thank you for taking my question. Charlie, I thought your comments in the prepared remarks about seeing more traction from AI applications and specifically in the data center were interesting. Obviously, a lot's happened in the AI space over the last few months. Could you maybe level set us on how much of your opportunity over time you see coming from actually in data center versus edge device, edge and embedded devices, where I think that's been your bread and butter for a while? Thank you.

[Charlie Janac, CEO at Arteris]

Yeah. I mean, basically. Our thesis is that over time, pretty much all electronic endpoints or edge devices are going to be connected to the data center. And so for each endpoint or edge device, there is some ratio of blades in the data center. And as everything becomes connected to the data center, the number of chips that's actually in these data centers goes to a very large number. So we're sort of following customer demand, and there's just a lot of attention on AI workloads in a data center. There's a lot of project starts. Obviously. NVIDIA is a very, very major player and will continue to be a major player. But some of these system houses are also designing some of their own chips for specific data acceleration of specific workloads. They're working on specific AI workloads and those kinds of things.

[Charlie Janac, CEO at Arteris]

So we see it as a major opportunity, and we're working with those customers, and we're increasingly starting to pivot our engineering to address the issues that are important to these data center companies, hyperscaler companies that are handling the high-end AI workloads. So over time, I mean, I think data center will be somewhere between 25%-30%, maybe 35% of our business. But right now, AI represents about 50% of all the design starts that we're involved with. So right now, there's a bit of a design start bonanza, but on a long-term basis, I would expect it to be about probably 35% or so.

[Joshua Buchalter, Senior Equity Research Analyst at TD Cowen]

Thank you for all the color there, and maybe, Nick, could you provide any comments or color on, it seems like you're getting a lot of good traction from FlexGen, which comes with higher ASP on the royalty and I'm guessing the licensing side as well. When should we expect that to start being a sort of meaningful needle mover in the model? Thank you both, and congrats again.

[Nick Hawkins, CFO at Arteris]

Josh, just to be clear, are you asking that question specifically regarding royalties or more generally on license revenue?

[Joshua Buchalter, Senior Equity Research Analyst at TD Cowen]

I was more on the royalty side.

[Nick Hawkins, CFO at Arteris]

Yeah. So I mean, FlexGen is accretive to both ASP and therefore license, but it's also accretive to royalties because it has more components as a product than the more junior NoC, the FlexNoC 5 that doesn't have the automation feature. So yes, if you look at somebody, for example, who's just kicked off a FlexGen cycle or a FlexGen deal with us, and most of those have come from the mid of this year onwards. And now you saw we had another four in addition to Altera and AMD in the third quarter. So it very much depends on the use case. There are some, most of the use cases right now are more in the server and FPGA environment, which don't have huge volumes, as you know. There are some which are more involved in higher volume. We're early stages yet.

[Nick Hawkins, CFO at Arteris]

We do expect a lot more penetration from FlexGen into some of the other areas that are perhaps higher volume. And of course, the biggest royalty area for us, which is about half of our total royalties, is actually from the automotive market. And so if you use FlexGen in automotive, for example, or automotive design today, and you start the design, it would be 2030-2031 before we started seeing the royalties from that. So there's a lot of pipeline stoking going on in royalties from this.

[Joshua Buchalter, Senior Equity Research Analyst at TD Cowen]

Thank you.

[Operator]

There are no further questions at this time. Mr. Janac, please proceed with closing remarks.

[Charlie Janac, CEO at Arteris]

Thank you, everyone, for your interest in Arteris. We're very excited about the current quarter, and we look forward to meeting you in the upcoming non-deal roadshows and investor conferences in the quarters ahead and updating you on our business progress. Thank you very much.

[Operator]

Ladies and gentlemen, this concludes your conference call for today. We thank you for participating and ask that you please disconnect your lines.

Participants

Executives

• Nick Hawkins, CFO
• Charlie Janac, CEO
• Nick Hawkins, EVP and CFO

Analysts

• Erica Mannion, Partner and Founder at Sapphire Investor Relations
• Gus Richard, Analyst at Northland
• Kevin Garrigan, Equity Research Analyst at Jefferies
• Kevin Cassidy, Analyst at Rosenblatt Securities
• Joshua Buchalter, Senior Equity Research Analyst at TD Cowen